Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Svetozar Zarnovicky
Extensive Multiple Sclerosis Reactivation After Switching From Fingolimod to Rituximab
Case Reports in Neurological Medicine
Related publications
Predictors for Multiple Sclerosis Relapses After Switching From Natalizumab to Fingolimod
Multiple Sclerosis
Neurology
Long-Term Evaluation of NEDA-3 Status in Relapsing-Remitting Multiple Sclerosis Patients After Switching From Natalizumab to Fingolimod
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Correction To: Switching From Natalizumab to Fingolimod Treatment in Multiple Sclerosis: Real Life Data From the Austrian MS Treatment Registry
Journal of Neurology
Neurology
Debate on the Treatment of Multiple Sclerosis: Experience From an Intractable Multiple Sclerosis Case With Rebound Syndrome After Fingolimod Cessation
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment
Neurology
Neurology
Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis
Case Reports in Medicine
Medicine
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Myeloid Cells as Target of Fingolimod Action in Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Fingolimod (FTY720) as an Anti-Multiple Sclerosis Oral Ultimate Therapy
Biosciences Biotechnology Research Asia
Biotechnology
Agronomy
Crop Science
Drug Discovery
